Skip to main content
. 2020 Nov 4;113(5):532–542. doi: 10.1093/jnci/djaa174

Table 1.

PROEAS items and the SISAQOL recommended statements they are derived from

SISAQOL statement PROEAS item Points
Taxonomy of research objectives (7 points)
RS 1 PRO endpoints were specified in the protocol 1
Hypothesis requirement was met as neededa 1
Endpoints were used to make appropriate conclusionsb 1
RS 2 Direction of the hypothesis was prespecified in the protocol if required 1
Clinical relevance for between-group differences was prespecified in the protocol 1
RS 3–8 Within-treatment group objective stated in the protocol 1
Clinical relevance for within-patient or within–treatment group change was predefined in the protocol 1
Recommending statistical methods (6 points)
RS 10 Statistical test comparing 2 groups done when appropriate 1
Provided P values for statistical significance 1
Tests used adjusted for baseline covariates 1
Tests used handled clustered data (repeated assessments) 1
Correction for multiple testing done appropriately 1
RS 11–15 Used at least 1 appropriate statistical test to evaluate the tested outcomec 1
Standardizing statistical terms related to missing data (6 points)
RS 16 A definition for missing data was reported 1
RS 18 Study did not consider PRO assessments for deceased patients as missing data 1
RS 21–22 Variable denominator rate reported 1
RS 19–20 Fixed denominator rate reported 1
RS 23 Absolute number for both numerators and denominators were reported 1
A CONSORT diagram or table reporting reasons for treatment discontinuation was provided 1
General handling of missing data (5 points)
RS 27 Study documented a priori the approach for handling missing data 1
RS 28 Item-level missing data handled according to the scoring algorithm of the instrument 1
RS 30 A method that allows the use of all available data was used to approach missing data 1
RS 31 Study did not use explicit imputation methods unless justified 1
RS 32 At least 2 different approaches to handle missing data were used 1
a

A hypothesis statement was required if PROs were a secondary endpoint and not required if PROs were an exploratory endpoint. CONSORT = Consolidated Standards of Reporting Trials; PRO = patient-reported outcome; PROEAS = Patient Reported Outcomes Endpoints Analysis Score; RS = recommended statement; SISAQOL = Standards in Analyzing Patient-Reported Outcomes and Quality of Life.

b

Comparative conclusions were considered appropriate if PROs were a primary or secondary endpoint only and inappropriate if PROs were exploratory endpoints.

c

Statistical tests were considered appropriate if they met the recommendations of the SISAQOL.